We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NODK icon
3001
NI Holdings
NODK
$320M
$7.35M ﹤0.01%
427,284
-1,411
-0.3% -$24.2K
NGS icon
3002
Natural Gas Services Group
NGS
$477M
$7.34M ﹤0.01%
598,848
+64,759
+12% +$763K
GNE icon
3003
Genie Energy
GNE
$384M
$7.34M ﹤0.01%
949,404
+1,384
+0.1% +$10.8K
FPRX
3004
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$7.32M ﹤0.01%
1,595,459
-26,107
-2% -$103K
TS icon
3005
Tenaris
TS
$26.8B
$7.28M ﹤0.01%
321,582
+23,141
+8% +$498K
STGW icon
3006
Stagwell
STGW
$2.24B
$7.28M ﹤0.01%
2,618,680
+70,924
+3% +$191K
PHX
3007
DELISTED
PHX Minerals
PHX
$7.27M ﹤0.01%
648,672
+38,617
+6% +$507K
PKD
3008
DELISTED
Parker Drilling Company
PKD
$7.26M ﹤0.01%
322,690
+61,388
+23% +$1.19M
MR
3009
DELISTED
Montage Resources Corporation Common Stock
MR
$7.24M ﹤0.01%
912,068
+57,727
+7% +$301K
CBAY
3010
DELISTED
Cymabay Therapeutics
CBAY
$7.24M ﹤0.01%
3,691,325
+13,931
+0.4% +$52.3K
MUX icon
3011
McEwen Inc
MUX
$1.18B
$7.23M ﹤0.01%
569,447
+47,334
+9% +$669K
FCCY
3012
DELISTED
1st Constitution Bancorp
FCCY
$7.22M ﹤0.01%
326,162
+76,174
+30% +$1.52M
CASI
3013
DELISTED
CASI Pharmaceuticals
CASI
$7.22M ﹤0.01%
233,549
-405
-0.2% -$13.1K
UBX
3014
DELISTED
Unity Biotechnology
UBX
$7.2M ﹤0.01%
99,881
+377
+0.4% +$26.6K
MFNC
3015
DELISTED
Mackinac Financial Corporation
MFNC
$7.2M ﹤0.01%
412,418
-1,191
-0.3% -$18.9K
CHMG icon
3016
Chemung Financial Corp
CHMG
$392M
$7.17M ﹤0.01%
168,641
-409
-0.2% -$17.9K
IIN
3017
DELISTED
IntriCon Corporation
IIN
$7.16M ﹤0.01%
397,506
+50,837
+15% +$974K
GFN
3018
DELISTED
General Finance Corporation
GFN
$7.15M ﹤0.01%
645,970
+44,135
+7% +$435K
SENS icon
3019
Senseonics Holdings Inc
SENS
$366M
$7.14M ﹤0.01%
389,872
-3,454
-0.9% -$68.1K
ARA
3020
DELISTED
American Renal Associates Holdings, Inc
ARA
$7.14M ﹤0.01%
688,726
+12,378
+2% +$106K
BXC icon
3021
BlueLinx
BXC
$706M
$7.13M ﹤0.01%
500,699
+96,188
+24% +$1.97M
DGICA icon
3022
Donegal Group Class A
DGICA
$714M
$7.13M ﹤0.01%
481,406
+1,519
+0.3% +$22.2K
DSKE
3023
DELISTED
Daseke, Inc. Common Stock
DSKE
$7.11M ﹤0.01%
2,248,425
-10,480
-0.5% -$30.7K
EVC icon
3024
Entravision Communication
EVC
$1.1B
$7.1M ﹤0.01%
2,710,892
-68,594
-2% -$187K
CSLT
3025
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$7.1M ﹤0.01%
5,335,717
-1,270,375
-19% -$1.77M

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.